Livagen Peptide
Hepatic bioregulatory tetrapeptide (Lys-Glu-Asp-Ala). Researched for liver function normalization and chromatin DNA decondensation effects.
This compound is currently in our development pipeline. Enter your email to be notified when it becomes available for research purchase.
Quick Facts
| SKU | LIV-001 |
|---|---|
| Sequence | Lys-Glu-Asp-Ala |
| Purity | ≥98% |
| Physical Form | Lyophilized Powder |
| Storage | Store at -20°C |
What is Livagen (Lys-Glu-Asp-Ala)?
Hepatic tetrapeptide shown to cause chromatin decondensation in hepatocyte nuclei, reactivating genes silenced by aging. This epigenetic mechanism allows liver cells to resume production of albumin, clotting factors, and detoxification enzymes.
Frequently Asked Questions
What is unique about Livagen mechanism?
Livagen causes chromatin decondensation — it physically unpacks tightly wound DNA in aging hepatocytes, reactivating silenced genes. This is a direct epigenetic mechanism unique among bioregulatory peptides.
For laboratory and research use only. Not intended for human or animal consumption. All product information is derived from published preclinical research and does not constitute medical advice or claims.